Filing Details

Accession Number:
0001179110-16-032655
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-12-09 11:37:49
Reporting Period:
2016-12-07
Filing Date:
2016-12-09
Accepted Time:
2016-12-09 11:37:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1113481 Medicines Co MDCO Pharmaceutical Preparations (2834) 043324394
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1557341 T Christopher Cox 8 Sylvan Way
Parsippany NJ 07054
Evp & Chief Corp. Dev. Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-12-07 89,000 $33.33 154,655 No 4 P Indirect See footnote
Common Stock Acquisiton 2016-12-08 16,500 $32.52 171,155 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
No 4 P Indirect See footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 33,670 Direct
Footnotes
  1. Represents the weighted average purchase price of the shares purchased ranging from a low of $32.73 to a high of $33.49 per share. The reporting person undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price for this footnote (1) and footnote (3).
  2. The reporting person holds a power of attorney with respect to this account. Members of the reporting person's immediate family may be considered to have a pecuniary interest in this account. The reporting person disclaims beneficial ownership of the shares held by this account except to the extent of his pecuniary interest therein.
  3. Represents the weighted average purchase price of the shares purchased ranging from a low of $32.13 to a high of $32.87 per share.